In 14 patients (12.3%) with HR+/HER2+ breast cancer was not administered endocrine therapy: in 3 patients due to values of ER and PgR less than or equal to 10% and in other 11 patients due to unexplained causes. This evidence concerns the gene PGR and breast cancer.